EU And India Bury Hatchet Over Drug Seizures But Companies Fear ACTA May Bring More Pains
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Leading pharmaceutical lobby groups - the Indian Drug Manufacturers Association and the Indian Pharmaceutical Alliance - cautiously welcomed the resolution of a trade dispute with the European Union that for more than two years saw random seizure of several generic drug consignments from Indian companies at select European ports
You may also be interested in...
Headway Seen In EU-India FTA Talks, Commerce Ministry Joint Secretary Says
Disputes over EU blockades of Indian drug shipments are still on the negotiation table, says Commerce Ministry. India hopes to initiate talks with China as well.
India Says Counterfeit Drugs Should Be Handled By WTO - Not WHO
MUMBAI - Years of strong opposition from the Indian government, bolstered by recent support in that effort by some Latin American, African and South-East Asian countries, has exerted pressure on the World Health Assembly to establish a working group to handle the controversy surrounding the definition of "substandard" and "counterfeit" drugs
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).